Millipore Sigma Vibrant Logo

OP93 Anti-BRCA1 (Ab-2) Mouse mAb (MS13)

Anti-BRCA1 (Ab-2), mouse monoclonal, clone MS13, recognizes ~220 kDa BRCA1 in MCF-7 cells. It is validated for Western blotting, immunofluorescence, immunoprecipitation, and for paraffin sections.

Anti-BRCA1 (Ab-2) Mouse mAb (MS13): MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: Anti-Breast Cancer Susceptibility Protein

View Products on Sigmaaldrich.com
OP93
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

Species ReactivityHostAntibody Type
HMMonoclonal Antibody

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
OP93-100UG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Fiala di plastica 100 μg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewRecognizes the ~220 kDa BRCA1 protein in MCF-7 cells. Does not react with blood group antigens or growth factor receptors such as EGFR. Sold under license of U.S. Patent 5,753,441 and 6,162,897.
      Catalogue NumberOP93
      Brand Family Calbiochem®
      SynonymsAnti-Breast Cancer Susceptibility Protein
      References
      ReferencesScully, R., et al. 1996. Science 272, 123.
      Gudas, J.M., et al. 1996. Cell Growth Differ. 7, 717.
      Vaughn, J.P., et al. 1996. Cell Growth Differ. 7, 711.
      Goldgar, D.E. and Reilly, P.R. 1995. Nat. Genet. 11, 113.
      Merajver, S.D., et al. 1995. Clin. Can. Res. 1, 539.
      Merajver, S.D., et al. 1995. Nat. Genet. 9, 439.
      Struewing, J.P., et al. 1995. Nat. Genet. 11, 198.
      Thompson, M.E., et al. 1995. Nat. Genet. 9, 444.
      Futreal, P.A., et al. 1994. Science 266, 120.
      Miki, Y., et al. 1994. Science 266, 66.
      Product Information
      DeclarationSold under license of U.S. Patents 5,753,441 and 6,162,897.
      FormLiquid
      FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
      Positive controlMCF7 cells
      Preservative≤0.1% sodium azide
      Quality LevelMQ100
      Applications
      Application ReferencesImmunoblotting, Immunoprecipitation, Immunofluorescence, Paraffin Sections Scully, R., et al. 1996. Science 272, 123.
      Key Applications Immunoblotting (Western Blotting)
      Immunofluorescence
      Immunoprecipitation
      Paraffin Sections
      Application NotesImmunoblotting (2 µg/ml, chemiluminescence; see application references)
      Immunofluorescence (see application references)
      Immunoprecipitation (see application references)
      Paraffin Sections (see application references)
      Application CommentsAntibody should be titrated for optimal results in individual systems.
      Biological Information
      Immunogenrecombinant, human BRCA1
      ImmunogenHuman
      Epitopewithin amino acids 1-304
      CloneMS13
      HostMouse
      IsotypeIgG₁
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Yes
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      OP93-100UG 04055977209693

      Documentation

      Anti-BRCA1 (Ab-2) Mouse mAb (MS13) MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Anti-BRCA1 (Ab-2) Mouse mAb (MS13) Certificati d'Analisi

      TitoloNumero di lotto
      OP93

      Riferimenti bibliografici

      Panoramica delle referenze
      Scully, R., et al. 1996. Science 272, 123.
      Gudas, J.M., et al. 1996. Cell Growth Differ. 7, 717.
      Vaughn, J.P., et al. 1996. Cell Growth Differ. 7, 711.
      Goldgar, D.E. and Reilly, P.R. 1995. Nat. Genet. 11, 113.
      Merajver, S.D., et al. 1995. Clin. Can. Res. 1, 539.
      Merajver, S.D., et al. 1995. Nat. Genet. 9, 439.
      Struewing, J.P., et al. 1995. Nat. Genet. 11, 198.
      Thompson, M.E., et al. 1995. Nat. Genet. 9, 444.
      Futreal, P.A., et al. 1994. Science 266, 120.
      Miki, Y., et al. 1994. Science 266, 66.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision03-October-2007 RFH
      SynonymsAnti-Breast Cancer Susceptibility Protein
      ApplicationImmunoblotting (2 µg/ml, chemiluminescence; see application references)
      Immunofluorescence (see application references)
      Immunoprecipitation (see application references)
      Paraffin Sections (see application references)
      DescriptionPurified mouse monoclonal antibody generated by immunizing mice with the specified iummunogen and fusing splenocytes with NS1 mouse myeloma cells. Recognizes the ~220 kDa BRCA1 protein.
      BackgroundInactivation of the BRCA1 gene, located at 17q21, is responsible for some forms of familial breast and ovarian cancer and sporadic ovarian cancer. BRCA1 encodes a protein of 1863 amino acids with an amino-terminal domain that exhibits similarity to the zinc-ring domain found in several regulatory and transcription factors. Mutations that disrupt this domain are some of the most frequently occurring ones linked to breast and ovarian cancer. Inhibition of BRCA1 expression leads to accelerated growth of mammary cells in vitro while loss of expression is observed during progression from benign disease to metastatic breast cancer suggesting that BRCA1 serves as a negative growth regulator. The ~220 kDa BRCA1 protein is expressed predominantly in the nucleus and appears to undergo cell cycle regulation with mRNA expression induced prior to DNA synthesis.
      HostMouse
      Immunogen speciesHuman
      Immunogenrecombinant, human BRCA1
      Epitopewithin amino acids 1-304
      CloneMS13
      IsotypeIgG₁
      Specieshuman
      Positive controlMCF7 cells
      FormLiquid
      FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
      Concentration Label Please refer to vial label for lot-specific concentration
      Preservative≤0.1% sodium azide
      CommentsAntibody should be titrated for optimal results in individual systems.
      Storage +2°C to +8°C
      Do Not Freeze Yes
      Toxicity Standard Handling
      ReferencesScully, R., et al. 1996. Science 272, 123.
      Gudas, J.M., et al. 1996. Cell Growth Differ. 7, 717.
      Vaughn, J.P., et al. 1996. Cell Growth Differ. 7, 711.
      Goldgar, D.E. and Reilly, P.R. 1995. Nat. Genet. 11, 113.
      Merajver, S.D., et al. 1995. Clin. Can. Res. 1, 539.
      Merajver, S.D., et al. 1995. Nat. Genet. 9, 439.
      Struewing, J.P., et al. 1995. Nat. Genet. 11, 198.
      Thompson, M.E., et al. 1995. Nat. Genet. 9, 444.
      Futreal, P.A., et al. 1994. Science 266, 120.
      Miki, Y., et al. 1994. Science 266, 66.
      Application referencesImmunoblotting, Immunoprecipitation, Immunofluorescence, Paraffin Sections Scully, R., et al. 1996. Science 272, 123.